Andy Pasternak is EVP, Chief Strategy Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2021, when has been sold 6,526 shares (Ordinary Shares) at a price of $73.28 per share, resulting in proceeds of $478,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Andy Pasternak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2021
SELL
Payment of exercise price or tax liability
$478,225 $73.28 p/Share
6,526 Reduced 28.43%
16,429 Ordinary Shares
Jan 05 2021
BUY
Exercise of conversion of derivative security
-
14,513 Added 38.73%
22,955 Ordinary Shares
Nov 01 2020
SELL
Payment of exercise price or tax liability
$412,340 $74.93 p/Share
5,503 Reduced 39.46%
8,442 Ordinary Shares
Nov 01 2020
BUY
Exercise of conversion of derivative security
-
12,420 Added 47.11%
13,945 Ordinary Shares
AP

Andy Pasternak

EVP, Chief Strategy Officer
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP